Exploring the Therapeutic Potential of Marham Kharish Jadeed in Chronic Eczema: A Case Report
Abstract
Eczema, known as Nar-e-Farsi in Unani medicine, is a chronic inflammatory skin disorder characterized by itching, erythema, vesiculation, and lichenification. It significantly affects quality of life and often shows recurrent episodes despite conventional treatment. Unani medicine emphasizes the role of humoral imbalance (Akhlat) in its pathogenesis and offers topical formulations aimed at restoring this balance. This case study explores the therapeutic efficacy of Marham Kharish Jadeed, a Unani formulation, in the management of chronic eczema A 55 year-old male patient presented with persistent pruritic rash on left foot was treated with Marham Kharish Jadeed, applied topically (8–10 gm) twice daily for 90 days. Clinical improvement was evaluated using EASI (Eczema Area and Severity Index), POEM (Patient-Oriented Eczema Measure), and VAS (Visual Analogue Scale for itching) at baseline and monthly follow-ups. Significant improvement was observed in both objective and subjective parameters. EASI score reduced from 18 to 2, POEM score from 22 to 3, and VAS score from 9 to 1 over 90 days. There was marked reduction in itching, oozing, and lesion size, with noticeable improvement in skin texture and color. No adverse effects or recurrence were reported during the study period. This case suggests that Marham Kharish Jadeed is a safe and effective Unani topical formulation for the management of chronic eczema. Further large-scale clinical studies are warranted to validate these findings.
Keywords: Eczema, Nar-e-Farsi, Unani medicine, Marham Kharish Jadeed, Case report, Chronic skin disease
Keywords:
Eczema, Nar-e-Farsi, Unani medicine, Marham Kharish Jadeed, Case report, Chronic skin diseaseDOI
https://doi.org/10.22270/jddt.v16i8.7890References
1. Majoosi. Kamil us Sana. Vol 2. New Delhi: Idara Kitab us Shifa, 2010, p.243.
2. Kabiruddin M. Tarjuma-e-Kabeer (Urdu translation of Sharah Asbab wa alamat). Hydrabad: Hikmat Book Depot, YNM, p.3, 256 257.
3. Tabri AHA. Moalijat Buqratiyah. New Delhi: Central Council for Research in Unani Medicine; 1997. Vol 2 p.221.
4. Jurjani I. Zakheera Khawarzam Shahi (Urdu translation by Khan HH). New Delhi: Idara Kitab ul Shifa; 2010. Vol 8. 24-26 p.
5. Sina I. Nar-e-farsi: Alqanoon-fit-Tibb translated by Ghulam Husain Kintoori, Idara Kitab-us-Shifa, Kucha Chelan, Darya Ganj, New Delhi, 2010, 1260-1261.
6. Kabiruddin M, Tarjuma-e-Kabeer (Urdu translation of Sharah Asbab wa alamat). Vol. 3, Hydrabad: Hikmat Book Depot, YNM, p. 256-257.
7. Quamri. Ghina Muna. New Delhi: Central Council for Research in Unani Medicine, 2008. p. 492-93.
8. Neena Khanna. Illustrated Synopsis of Dermatology and Sexually Transmitted Disease. Fourth edi. Elsevier; c2011.
9. Schmitt J, Apfelbacher CJ, Flohr C. Eczema. BMJ clinical evidence. 2011;1716(2011):1-41.
10. Langan SM, Mulick AR, Rutter CE, et al. Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study. Clinical and Experimental Allergy. DOI:10.1111/cea.14276 https://doi.org/10.1111/cea.14276 PMCid:PMC10946567
11. Griffiths CEM, Bleiker TO, Creamer D, Ingram JR. Rook’s Dermatology Handbook. First. John Wiley & Sons; c2022. https://doi.org/10.1002/9781394323043
12. Hegde P, Hemanth DT, Emmi SV, et al. A case discussion on eczema. International Journal of Ayurveda Research. 2010 Oct;1(4):268-270. DOI: 10.4103/0974-7788.76792. PMID: 21455456; PMCID: PMC3059451. https://doi.org/10.4103/0974-7788.76792 PMid:21455456 PMCid:PMC3059451
13. Anonymous. National Formulary of Unani Medicine, part V. CCRUM. New Delhi, Ministry of Health and Family Welfare. Government of India;2008:115-117.
Published
Abstract Display: 98
PDF Downloads: 129
PDF Downloads: 35 How to Cite
Issue
Section
Copyright (c) 2026 Syed Isra Ali , Mohammad Naseem Khan, Atiya Anjum, Mehzabi, Sadaf

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.